MEMS Sensor Patent Landscape 2026
MEMS Sensor Patent Landscape in 2026
The MEMS sensor patent field spans 1,163 patent families and is moderately concentrated, with the top five filers holding 18% of the hundred largest filers’ combined total. Annual volume peaked in 2020 and has since eased, placing the field in a declining phase — though material analysis and biosensing remain the dominant technology routes driving continued activity.
Ningkasai Tech leads a fragmented field with a clear tier gap at the top
Ningkasai Tech (Shanghai) Co Ltd holds the top position with 78 patent families, nearly double the second-ranked Koninklijke Philips NV and ANPAC Bio Medical Sci Co Ltd, which each hold 42 patent families. This gap defines a clear first-mover advantage at the apex of the ranking.
The top five filers — Ningkasai Tech, Koninklijke Philips, ANPAC Bio Medical, Sensirion AG, and Giatec Scientific — together account for 18% of the hundred largest filers’ combined output. Beyond this leading cluster, activity spreads across a long tail of specialists and university-affiliated entities, indicating a fragmented competitive structure.
| # | Applicant | Patent families | Share |
|---|---|---|---|
| 1 | Ningkasai Tech (Shanghai) Co Ltd | 78 | |
| 2 | Koninklijke Philips NV | 42 | |
| 3 | ANPAC Bio Medical Science Co Ltd | 42 | |
| 4 | Sensirion AG | 40 | |
| 5 | Giatec Scientific Inc | 39 | |
| 6 | Trimble Inc | 37 | |
| 7 | MAST Inc | 37 | |
| 8 | MSA Technology LLC | 34 | |
| 9 | Altivera LLC | 30 | |
| 10 | Hahn-Schickard Society for Applied Research | 30 |
| # | Applicant | Patent families | Share |
|---|---|---|---|
| 11 | Kyocera SLD Laser Inc | 28 | |
| 12 | Infineon Technologies AG | 28 | |
| 13 | F HOFFMANN LA ROCHE & CO AG | 27 | |
| 14 | VTT Technical Research Centre of Finland | 24 | |
| 15 | Qualcomm Inc | 23 | |
| 16 | Robert Bosch GmbH | 21 | |
| 17 | Fernandez Dennis S | 21 | |
| 18 | Board of Regents, The University of Texas System | 21 | |
| 19 | Atonarp Inc | 20 | |
| 20 | General Electric Co | 20 |
The leader’s emphasis on material analysis and biosensing (G01N sub-classes) signals that diagnostic and chemical sensing applications anchor the field’s most active IP corridor, creating both a density risk for late entrants in those sub-classes and reference points for differentiation in adjacent branches.
Filing counts for 2024–2026 are subject to publication lag and understate actual recent activity; the observed trough in those years should not be taken as a definitive measure of current market commitment. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
Filing volume peaked in 2020; material analysis dominates the technology mix
The annual filing trend and technology composition together reveal a field that built momentum through the late 2010s, crested around 2020, and has since moderated — while remaining structurally anchored in chemical and biological sensing applications.
Annual filing trend
Filings rose from 129 patent families in 2017 to a peak of 171 in 2020, then stepped down through 2021–2023 and appear sharply lower in 2024–2026. The 2024–2026 values are affected by publication lag and should be read as provisional minimums rather than confirmed declines.
↗ Hover for values · click a bar to ask EurekaTechnology composition
G01N (material analysis and testing) is by far the dominant IPC branch, reflecting the field’s centre of gravity in chemical, biological, and electrochemical sensing. G01S (radar, sonar, and positioning) is the second-largest branch, followed by A61B (diagnosis and surgery) and G01C (navigation and gyroscopes), confirming that MEMS sensors are deployed across sensing modalities well beyond pure microstructural devices (B81B and B81C together are relatively modest in this corpus).
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
MEMS sensor, MEMS sensor system and method for pro…
A MEMS sensor includes a sensor package and a membrane arranged in the sensor package, wherein a first partial volume of the sensor package adjoins a first main side of the membrane and a second partial volume of the sensor package adjoins a second main side of the membrane, wherein the second main side is arranged opposite the first main side. The MEMS… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Asset system control arrangement and method | 1,776 |
| 2 | Integrated biosensor and simulation system for dia… | 715 |
| 3 | Diagnostic radio frequency identification sensors … | 564 |
| 4 | Asset system control arrangement and method | 546 |
| 5 | Apparatus and process for sensing fluoro species i… | 493 |
| 6 | Apparatus and process for sensing fluoro species i… | 478 |
| 7 | Apparatus and process for sensing fluoro species i… | 475 |
| 8 | Intelligent fluid sensor for machinery diagnostics… | 454 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
What the competitive structure means for R&D strategy
Four structural dimensions — maturity, concentration, collaboration, and geography — shape the risk and opportunity profile for any new entrant or incumbent expanding its MEMS sensor portfolio.
Field is in a declining phase following a 2020 peak
Annual filings peaked at 171 patent families in 2020 and have eased materially since, consistent with a declining lifecycle stage. This suggests core MEMS sensor architectures are maturing and incremental differentiation is harder to sustain at the system level. R&D investment is most defensible in sub-fields that still show active filing, such as biosensing and positioning.
Lifecycle: DeclineModerate top-tier concentration with a long specialist tail
The top five filers hold 18% of the hundred largest filers’ combined total — meaningful but not dominant. Ningkasai Tech’s lead of 78 patent families is substantial relative to the second tier (42 each for Philips and ANPAC), but the long tail of 15+ filers each holding 20–39 patent families means no single player has locked up the field. Targeted portfolio building in specific application verticals remains viable.
Moderate concentrationANPAC Bio Medical anchors the most active co-filing cluster
The strongest co-filing relationships link ANPAC Bio Medical Sci Co Ltd with Changwei Systems Technology (Shanghai) Co Ltd and Ningkasai Tech (Shanghai) Co Ltd, each pair sharing 7 jointly filed patent families. ANPAC Bio Medical (Lishui) Co Ltd extends these links with an additional 6-family tie to each of those same partners. Hahn-Schickard and Fraunhofer represent a separate European collaborative cluster. These networks signal where integrated platform development is occurring.
Cluster-based collaborationUS-centric filing with selective European and PCT coverage
The United States is the dominant filing jurisdiction by a wide margin. Europe (EPO) and WIPO (PCT) are the next largest routes, reflecting international prosecution by the leading applicants. China and Germany follow, with Australia, India, and Canada forming a secondary tier. South Korea and Japan show limited coverage despite their importance as MEMS manufacturing bases, suggesting a potential gap in Asian market protection for some filers.
US-led, selective globalGo beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| ANPAC Bio Medical Science Co Ltd | Changwei Systems Technology (Shanghai) Co Ltd | 7 |
| ANPAC Bio Medical Science Co Ltd | Ningkasai Tech (Shanghai) Co Ltd | 7 |
| ANPAC Bio Medical Science (Lishui) Co Ltd | Changwei Systems Technology (Shanghai) Co Ltd | 6 |
| ANPAC Bio Medical Science (Lishui) Co Ltd | Ningkasai Tech (Shanghai) Co Ltd | 6 |
| ANPAC Bio Medical Science (Lishui) Co Ltd | Shanghai Xinshenpai Technology Co Ltd | 4 |
| ANPAC Bio Medical Science Co Ltd | ANPAC Bio Medical Science (Lishui) Co Ltd | 2 |
| ANPAC Bio Medical Science Co Ltd | Shanghai Xinshenpai Technology Co Ltd | 2 |
| Hahn-Schickard Society for Applied Research | Fraunhofer Society for the Promotion of Applied Research | 2 |
| Hahn-Schickard Society for Applied Research | HAHN-SCHICKARD INT GMBH | 2 |
| Hahn-Schickard Society for Applied Research | KUNDO XT GMBH | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
Ningkasai Tech leads in biosensing; Hahn-Schickard is the rising European challenger
The top two featured players illustrate contrasting strategies: one built on a large biosensing portfolio anchored in Chinese collaborative networks, the other a European applied-research institute with positive filing momentum in optical and acoustic sensing.
Ningkasai Tech (Shanghai) Co Ltd
Holds 78 patent families, the largest portfolio in the corpus. Technology emphasis is concentrated in G01N sub-classes covering material analysis and testing — specifically electrochemical sensing (G01N27), immunoassay and biochemical detection (G01N33), and automated sample analysis (G01N35). The company is deeply embedded in the ANPAC Bio Medical collaborative cluster, reinforcing a biosensing platform strategy. Momentum data for this applicant is not separately listed in the evidence.
patent families: 78Hahn-Schickard Society for Applied Research
Holds 30 patent families and is the only tracked applicant with confirmed positive recent momentum at +18% versus the prior period, distinguishing it from peers whose activity has contracted. Its technology focus spans optical sensing (G01N21), acoustic and ultrasonic methods (G01N29), and flow measurement (G01F1). It collaborates with Fraunhofer Society and Hahn-Schickard International GmbH, forming a German applied-research axis in the field.
patent families: 30| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| MSA Technology LLC | 4 | ▼ -86% |
| Hahn-Schickard Society for Applied Research | 13 | ▲ +18% |
| Infineon Technologies AG | 2 | ▼ -83% |
Under-served branches adjacent to the dominant sensing core
Several IPC branches appear at relatively low share within this corpus despite having plausible technical and commercial relevance to MEMS sensor deployment. These are observations of relative sparsity rather than validated market gaps, and entry feasibility depends on each organization’s existing capabilities.
B81B · Microstructural devices (MEMS) — core fabrication layer
With only 139 records and a 2% share of branch classifications, the dedicated MEMS microstructure branch (B81B) is notably sparse relative to the application-layer branches that dominate the corpus. Given that the field’s application branches (G01N, G01S, A61B) are crowded, filing in the underlying device architecture space may offer differentiation with lower citation density. The entry path favors teams with cleanroom fabrication and transducer-design expertise who can claim platform patents that support multiple application verticals.
Search this in Eureka →G01C · Distance, navigation & gyroscopes — inertial sensing
G01C (distance, navigation, and gyroscopes) appears in 197 records at 3% share, making it an adjacent but under-developed branch relative to the chemical/biological sensing core. Inertial MEMS (accelerometers, gyroscopes) underpin autonomous systems, industrial IoT, and wearables — all growing application contexts. Trimble Inc is the primary identified filer in this space with a G01S/G01C emphasis, but its focus skews toward GPS-augmented positioning. Pure inertial MEMS at the component level appears to have limited coverage in this corpus, suggesting room for specialized entrants with sensor-fusion or calibration IP.
Search this in Eureka →How leading applicants differ by technology branch emphasis
Strength of each leader across the main technology routes.
| Player | G01N 33 · Material analysis & testing | G01N 27 · Material analysis & testing | G01S 19 · Radar, sonar & positioning | G01N 29 · Material analysis & testing | G01N 21 · Material analysis & testing |
|---|---|---|---|---|---|
| ANPAC Bio Medical Science Co Ltd | Strong · 67 | Strong · 44 | Absent | Moderate · 17 | Moderate · 15 |
| Giatec Scientific Inc | Strong · 25 | Strong · 19 | Absent | Absent | Absent |
| ANPAC Bio Medical Science (Lishui) Co Ltd | Strong · 26 | Moderate · 12 | Absent | Absent | Absent |
| Hahn-Schickard Society for Applied Research | Absent | Absent | Absent | Strong · 16 | Strong · 22 |
| Sensirion AG | Strong · 20 | Strong · 13 | Absent | Absent | Absent |
| MSA Technology LLC | Absent | Strong · 33 | Absent | Absent | Absent |
| MAST Inc | Strong · 31 | Absent | Absent | Absent | Absent |
Frequently asked questions
The corpus covers 1,163 patent families. This is the base count for trend analysis and portfolio sizing; individual applicant rankings are expressed in patent families as well.
Ningkasai Tech (Shanghai) Co Ltd holds the largest portfolio with 78 patent families, ahead of Koninklijke Philips NV and ANPAC Bio Medical Sci Co Ltd, which each hold 42 patent families.
Annual filings peaked at 171 patent families in 2020, up from 129 in 2017. Since 2020, volume has stepped down each year through 2023. Figures for 2024–2026 are affected by publication lag and should be treated as provisional minimums rather than confirmed activity levels.
G01N (material analysis and testing) is the dominant branch by a wide margin, followed by G01S (radar, sonar, and positioning) and A61B (diagnosis and surgery). The dedicated MEMS device branches B81B and B81C together are comparatively small, reflecting that the corpus is organized primarily around sensing applications rather than device fabrication per se.
The United States is the leading filing jurisdiction. Europe (EPO) and WIPO (PCT) are the next most common routes, followed by China and Germany. South Korea and Japan show limited coverage in this corpus despite their manufacturing significance in the broader MEMS industry.
The most active co-filing relationships link ANPAC Bio Medical Sci Co Ltd with Changwei Systems Technology (Shanghai) Co Ltd and with Ningkasai Tech (Shanghai) Co Ltd, each pair sharing 7 jointly filed patent families. ANPAC Bio Medical Sci (Lishui) Co Ltd extends this cluster with 6-family ties to the same partners. In Europe, Hahn-Schickard Society for Applied Research co-files with Fraunhofer Society for the Promotion of Applied Research.
Ready to map your own MEMS sensor patent landscape?
Join 18,000+ innovators using PatSnap Eureka to map any technology landscape: search 2B+ patents and papers, surface key assignees, and generate a report like this in minutes.
Disclaimer. This page is generated from PatSnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. PatSnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.